
The Pharma Letter Podcast
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
Podcasting since 2021 • 34 episodes
The Pharma Letter Podcast
Latest Episodes
Nouscom bets on dual vaccine strategy to outsmart cancer
This week on The Pharma Letter Podcast, we’re joined by Marina Udier, chief executive of Nouscom — a biotech company developing cancer vaccines.Founded in 2015, the firm is working on cancer vaccines that use a viral vector platform to t...
•
Season 1
•
Episode 35
•
19:59

Is this a revolution in Alzheimer's?
This week on The Pharma Letter Podcast, we’re joined by Howard Fillit, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation (ADDF).As the FDA approval of anti-amyloid drugs like lecanemab and donanemab marks ...
•
Season 1
•
Episode 34
•
20:55

Why Boehringer and GSK are betting on Ochre
This week on The Pharma Letter Podcast, we’re joined by Quin Wills, co-founder and chief scientific officer of UK biotech Ochre Bio.A physician-scientist with a background in genomics and computational biology, Quin has spent much of hi...
•
Season 1
•
Episode 33
•
18:53
.png)
ICON's AI strategy: faster, smarter trials
This week on The Pharma Letter Podcast, we are joined by Tony Clarke, senior VP of IT digital operations at ICON (Nasdaq: ICLR).As a leader in digital transformation within clinical research, Tony has been at the forefront of implementin...
•
Season 1
•
Episode 32
•
15:59

How real-time data could transform clinical trials
In this week’s podcast, we welcome Iddo Peleg, CEO and co-founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. As we move headlong into 2025, a year that appears set to be cha...
•
Season 1
•
Episode 31
•
15:14
.png)